Research / AMSF / Fundamental state Inspectable configuration
State dimensions Filing 0001193125-26-173630 Insurance
Cash 25th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.cash
$34.2M · CORE · VALID
Policy-benefit growth 100th Own-history percentile · N=8
Evidence method Yoy · gp.insurance.policy_benefits
15.64% · OPTIONAL · VALID
Net-income growth 50th Own-history percentile · N=8
Evidence method Yoy · gp.fundamentals.net_income
-8.98% · CORE · VALID
Premium growth 100th Own-history percentile · N=8
Evidence method Yoy · gp.insurance.premiums
8.98% · CORE · VALID
Revenue growth 100th Own-history percentile · N=8
Evidence method Yoy · gp.fundamentals.revenue
10.32% · CORE · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 10 states History building
Mar 31, 2024 0/5 normalized Level 3 Jun 30, 2024 0/5 normalized Level 3 Sep 30, 2024 0/5 normalized Level 3 Dec 31, 2024 0/5 normalized Level 3 Mar 31, 2025 1/5 normalized Level 3 Jun 30, 2025 1/5 normalized Level 3 Sep 30, 2025 1/5 normalized Level 3 Dec 31, 2025 1/5 normalized Level 3 Mar 31, 2026 5/5 normalized Level 3 Jun 30, 2026 5/5 normalized Level 3 Period transition
What moved in the state? Cash Decreased
Previous $61.9M
Current $34.2M
Delta -$27.7M Claims Growth Increased
Previous 8.06%
Current 15.64%
Delta 7.58% Earnings Growth Increased
Previous -14.96%
Current -8.98%
Delta 5.97% Premium Growth Increased
Previous 4.59%
Current 8.98%
Delta 4.39% Revenue Growth Increased
Previous 2.66%
Current 10.32%
Delta 7.67% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.